These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31195912)

  • 1. Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles - development, characterisation, and
    Hameed A; Gallagher LB; Dolan E; O'Sullivan J; Ruiz-Hernandez E; Duffy GP; Kelly H
    J Microencapsul; 2019 May; 36(3):267-277. PubMed ID: 31195912
    [No Abstract]   [Full Text] [Related]  

  • 2. Electron dispersive X-ray spectroscopy and degradation properties of hyaluronic acid decorated microparticles.
    Serri C; Frigione M; Ruponen M; Urtti A; Borzacchiello A; Biondi M; Itkonen J; Mayol L
    Colloids Surf B Biointerfaces; 2019 Sep; 181():896-901. PubMed ID: 31382338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction and bioactivity evaluation of hepatocyte growth factor-loaded poly (lactic-co-glycolic acid) nanoparticles].
    Xian WJ; Wang XE; Zhang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):217-223. PubMed ID: 29502063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
    Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
    J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of hyaluronic acid and PLGA particles as hybrid systems for viscosupplementation in osteoarthritis.
    Mota AH; Direito R; Carrasco MP; Rijo P; Ascensão L; Viana AS; Rocha J; Eduardo-Figueira M; Rodrigues MJ; Custódio L; Kuplennik N; Sosnik A; Almeida AJ; Gaspar MM; Reis CP
    Int J Pharm; 2019 Mar; 559():13-22. PubMed ID: 30664999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained Release of Risedronate from PLGA Microparticles Embedded in Alginate Hydrogel for Treatment of Bony Lesions.
    Azari G; Aghayan S; Seyedjafari E
    Iran Biomed J; 2022 Mar; 26(2):124-31. PubMed ID: 35090303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
    Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
    Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA/chitosan-heparin composite microparticles prepared with microfluidics for the construction of hMSC aggregates.
    Ge M; Sheng Y; Qi S; Cao L; Zhang Y; Yang J
    J Mater Chem B; 2020 Nov; 8(43):9921-9932. PubMed ID: 33034328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
    Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
    AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRG1 PLGA MP locally induce macrophage polarisation toward a regenerative phenotype in the heart after acute myocardial infarction.
    Pascual-Gil S; Abizanda G; Iglesias E; Garbayo E; Prósper F; Blanco-Prieto MJ
    J Drug Target; 2019; 27(5-6):573-581. PubMed ID: 30289743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
    Gomes AJ; Faustino AS; Machado AE; Zaniquelli ME; de Paula Rigoletto T; Lunardi CN; Lunardi LO
    Drug Deliv; 2006; 13(6):447-54. PubMed ID: 17002973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically active microcarriers associated with thermosensitive hydrogel as a growth factor releasing biomimetic 3D scaffold for cardiac tissue-engineering.
    Karam JP; Muscari C; Sindji L; Bastiat G; Bonafè F; Venier-Julienne MC; Montero-Menei NC
    J Control Release; 2014 Oct; 192():82-94. PubMed ID: 24998940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts.
    Pascual-Gil S; Simón-Yarza T; Garbayo E; Prosper F; Blanco-Prieto MJ
    J Control Release; 2015 Dec; 220(Pt A):388-396. PubMed ID: 26546270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery.
    Ismail R; Sovány T; Gácsi A; Ambrus R; Katona G; Imre N; Csóka I
    Pharm Res; 2019 May; 36(7):99. PubMed ID: 31087188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides.
    Kharel S; Gautam A; Dickescheid A; Loo SCJ
    Pharm Res; 2018 Aug; 35(10):185. PubMed ID: 30073514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
    Hlaing SP; Kim J; Lee J; Hasan N; Cao J; Naeem M; Lee EH; Shin JH; Jung Y; Lee BL; Jhun BH; Yoo JW
    Eur J Pharm Biopharm; 2018 Nov; 132():94-102. PubMed ID: 30223029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
    Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
    J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis.
    Quadros HC; Santos LMF; Meira CS; Khouri MI; Mattei B; Soares MBP; de Castro-Borges W; Farias LP; Formiga FR
    Int J Pharm; 2020 Feb; 576():118997. PubMed ID: 31893542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.